Aneuploidies, deletion, and overexpression of TP53 gene in intestinal metaplasia of patients without gastric cancer

Cancer Genetics and Cytogenetics

Volumn 153, Issue 2, 2004, Pages 127-132

  César, Ana Cristina Gobbo ^a   Borim, Aldenis Albaneze ^b   Caetano, Alaor ^b   Cury, Patrícia Maluf ^b   Silva, Ana Elizabete ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b HOSPITAL DE BASE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DISRUPTION; GENE FREQUENCY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CANCER; TETRASOMY; TRISOMY;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CHROMOSOME ABERRATIONS; GENE DELETION; GENES, P53; HUMANS; INTESTINAL DISEASES; INTESTINAL NEOPLASMS; METAPLASIA; MIDDLE AGED; NEOPLASM STAGING;

EID: 9944235734     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.01.017     Document Type: Article

References (48)

1. P. Correa, and Y.-H. Shiao Phenotypic and genotypic events in gastric carcinogenesis Cancer Res 54 Suppl 1994 1941s 1943s
2. Y.H. Shiao, M. Rugge, P. Correa, H.P. Lehmann, and W.D. Scheer p53 alteration in gastric precancerous lesions Am J Pathol 144 1994 511 517
3. M.F. Dixon, R.M. Genta, J.H. Yardley, and P. Correa Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994 Am J Surg Pathol 20 1996 1161 1181
4. T. Rokkas, M.I. Filipe, and G.E. Sladen Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up Gut 32 1991 1110 1113
5. P. Tosi, M.I. Filipe, P. Luzi, C. Miracco, R. Santopietro, R. Lio, V. Sforza, and P. Barbini Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry J Pathol 169 1993 73 78
6. Y. Gomyo, M. Osaki, N. Kaibara, and H. Ito Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP Int J Cancer 66 1996 594 599
7. M.I. Filipe, N. Muñoz, I. Matko, I. Kato, V. Pompe-Kim, A. Jutersek, S. Teuchmann, M. Benz, and T. Prijon Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia Int J Cancer 57 1994 324 329
8. E.J. Kuipers Exploring the link between Helicobacter pylori and gastric cancer [Review] Aliment Pharmacol Ther 13 Suppl 1999 3 11
9. E. Tahara Molecular mechanism of stomach carcinogenesis J Cancer Res Clin Oncol 119 1993 265 272
10. W. Yasui, N. Oue, H. Kuniyasu, R. Ito, E. Tahara, and H. Yokozaki Molecular diagnosis of gastric cancer: present and future Gastric Cancer 4 2001 113 121
11. G. Stemmermann, S.C. Heffelfinger, A. Noffsinger, Y.Z. Hui, M.A. Miller, and C.M. Fenoglio-Preiser The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors Hum Pathol 25 1994 968 981
12. A. Ochiai, Y. Yamauchi, and S. Hirohashi p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia Int J Cancer 69 1996 28 33
13. K. Kobayashi, T. Okamoto, S. Takayama, M. Akiyama, T. Ohno, and H. Yamada Genetic instability in intestinal metaplasia is a frequent event leading to well-differentiated early adenocarcinoma of the stomach Eur J Cancer 36 2000 1113 1119
14. S.S. Kim, C.S. Bhang, K.O. Min, H.S. Chae, S.W. Choi, C.D. Lee, K.W. Lim, I.S. Chung, and D.H. Park p53 mutations and microsatellite instabilities in the subtype of intestinal metaplasia of the stomach J Korean Med Sci 17 2002 490 496
15. M. Nakajima, H. Sawada, Y. Yamada, A. Watanabe, M. Tatsumi, J. Yamashita, M. Matsuda, T. Sakaguchi, T. Hirao, and H. Nakano The prognostic significance of amplification and overexpression of c-met and c-erbB-2 in human gastric carcinomas Cancer 88 2000 1894 1902
16. Y. Takano, Y. Kato, P.J. van Diest, M. Masuda, H. Mitomi, and I. Okayasu Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases Am J Pathol 156 2000 585 594
17. N. Munoz, I. Kato, S. Peraza, G. Lopez, E. Carrillo, H. Ramirez, J. Vivas, D. Castro, V. Sanchez, O. Andrade, E. Buiatti, and W. Oliver Prevalence of precancerous lesions of the stomach in Venezuela Cancer Epidemiol Biomarkers Prev 5 1996 41 46
18. J. Valle, and J.P. Gisbert Helicobacter pylori infection and precancerous lesions of the stomach Hepatogastroenterology 48 2001 1548 1551
19. P. Lauren The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 1965 31 49
20. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning: a laboratory manual 2nd edition 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
21. S.Z. Abdel-Rahman, R.A. El-Zein, W.A. Anwar, and W.W. Au A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies Cancer Lett 106 1996 229 233
22. M. Hammar, T. Tysabewicz, T. Wadstrom, and P.W. O'Toole Rapid detection of Helicobacter pylori in gastric biopsy material by polymerase chain reaction J Clin Microbiol 30 1992 54 58
23. C.L. Clayton, H. Kleanthous, P.J. Coates, D.D. Morgan, and S. Tabaqchali Sensitive detection of Helicobacter pylori by using polymerase chain reaction J Clin Microbiol 30 1992 192 200
24. D. Dzierzanowska, A. Gzyl, E. Rozynek, E. Augustynowicz, U. Wojda, U.D. Celinska-Cedro, M. Sankowska, and T. Wadström PCR for identification and typing of Helicobacter pylori isolated from children J Physiol Pharmacol 47 1996 101 114
25. N. Barril, A.B. Carvalho-Sales, and E.H. Tajara Detection of numerical chromosome anomalies in interphase cells of benign and malignant thyroid lesions using fluorescence in situ hybridization Cancer Genet Cytogenet 117 2000 50 56
26. D.A. Eastmond, M. Schuler, and D.S. Rupa Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells Mutat Res 348 1995 153 162
27. P.H. Duesberg Are cancers dependent on oncogenes or on aneuploidy? Cancer Genet Cytogenet 143 2003 89 91
28. L. Zhang, W. Zhou, V.E. Velculescu, S.E. Kern, R.H. Hruban, S.R. Hamilton, B. Vogelstein, and K.W. Kinzler Gene expression profiles in normal and cancer cells Science 276 1997 1268 1272
29. J.R. Pollack, T. Sorlie, C.M. Perou, C.A. Rees, S.S. Jeffrey, P.E. Lonning, R. Tibshirani, D. Botstein, A.L. Borresen-Dale, and P.O. Brown Microarray analysis reveals a major direct role of DNA copy number alterations in the transcriptional program of human breast tumors Proc Natl Acad Sci U S A 99 2002 12963 12968
30. L.J. van't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T. Witteveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Linsley, R. Bernards, and S.H. Friend Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
31. P. Duesberg, C. Rausch, D. Rasnick, and R. Hehlmann Genetic instability of cancer cells is proportional to their degree of aneuploidy Proc Natl Acad Sci U S A 95 1998 13692 13697
32. P. Duesberg, R. Li, D. Rasnick, C. Rausch, A. Willer, A. Kraemer, G. Yerganian, and R. Hehlmann Aneuploidy precedes and segregates with chemical carcinogenesis Cancer Genet Cytogenet 119 2000 83 93
33. H. Igaki, H. Sasaki, Y. Tachimori, H. Kato, H. Watanabe, T. Kimura, Y. Harada, T. Sugimura, and M. Terada Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract Cancer Res 55 1995 3421 3423
34. Y. Hao, J. Zhang, C. Yi, and W. Qian Abnormal change of p53 gene in gastric and precancerous lesions and APC gene deletion in gastric carcinoma and near tissues J Tongji Med Univ 17 1997 75 78
35. C. Sakakura, T. Mori, T. Sakabe, Y. Ariyama, T. Shinomiya, K. Date, A. Hagiwara, T. Yamaguchi, T. Takahashi, Y. Nakamura, T. Abe, and J. Inazawa Gains, losses and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization Genes Chromosomes Cancer 24 1999 299 305
36. M. Nakajima, H. Sawada, Y. Yamada, A. Watanabe, M. Tatsumi, J. Yamashita, M. Matsuda, T. Sakaguchi, T. Hirao, and H. Nakano The prognostic significance of amplification and overexpression of c-met and c-erbB-2 in human gastric carcinomas Cancer 85 1999 1894 1902
37. C. Marinone, A. Martinetti, M. Mestriner, E. Seregni, M. Geuna, L. Ferrari, G. Strola, L. Bonardi, E. Fea, and E. Bombardieri p53 evaluation in gastric mucosa of patients with chronic Helicobacter pylori infection Anticancer Res 21 2001 1115 1118
38. F. Petersson, K. Borch, and L.E. Franzen Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H. pylori infection Dig Dis Sci 47 2002 1558 1566
39. G.Y. Lauwers, S.J. Wahl, J. Melamed, and R.R. Rojas-Corona p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps [Erratum: Am J Gastroenterol 1994;89:300.] Am J Gastroenterol 88 1993 1916 1919
40. A. Romiti, A. Moretti, A. Vecchione, R. Muraro, M.L. Feudi, V. Rinaldi, R. Mancini, C. Valli, A. Mozzicafreddo, L. Frati, and S. Tomao Analysis of p53 expression in precancerous and malignant gastric mucosa Oncol Rep 5 1998 109 113
41. Y. Kakeji, D. Korenaga, S. Tsujitani, H. Baba, H. Anai, Y. Maehara, and K. Sugimachi Gastric cancer with p53 overexpression has high potential for metastasizing to lymph nodes Br J Cancer 67 1993 589 593
42. Y. Yonemura, S. Fushida, K. Tsugawa, I. Ninomiya, L. Fonseca, A. Yamaguchi, I. Miyazaki, T. Urano, and H. Shiku Correlation of p53 expression and proliferative activity in gastric cancer Anal Cell Pathol 5 1993 277 288
43. B.V. Joypaul, E.L. Newman, D. Hopwood, A. Grant, S. Qureshi, D.P. Lane, and A. Cuschieri Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study J Pathol 170 1993 279 283
44. E. Ioachim, A. Goussia, D. Stefanou, and N.J. Agnantis Expression of p53 protein in gastric cancer: an immunohistochemical study with correlation to proliferation activity Anticancer Res 17 1997 513 517
45. L. Fonseca, Y. Yonemura, X. De Aretxabala, A. Yamaguchi, K. Miwa, and I. Miyazaki p53 detection as a prognostic factor in early gastric cancer Oncology 51 1994 485 490
46. A.J. Levine, J. Momand, and C.A. Finlay The p53 tumour suppressor gene Nature 351 1991 453 456
47. K. Dolan, S.J. Walker, J. Gosney, J.K. Field, and R. Sutton TP53 mutations in malignant and premalignant Barrett's esophagus Dis Esophagus 16 2003 83 89
48. J. Sanz-Ortega, S. Hernandez, M.C. Saez, E. Sierra, G. Sanz-Ortega, A. Torres, J.L. Balibrea, J. Sanz-Esponera, and M.J. Merino 3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia Hepatogastroenterology 50 2003 404 407